minute read
Drug manufacturer Eli Lilly announced Wednesday it will cap the out-of-pocket cost of its insulin at $35 a month. The move will bring relief to more than 300,000 Coloradans living with diabetes.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
